First Light Asset Management, LLC
- SEC CIK
- 0001600004
- 最新申報
- 2026/8/14
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/15 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 37
- 較 2024 年第 4 季 +1
- 總值
- $8.76 億
- 較 2024 年第 4 季 −$1.69 億 (−16.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ANABAnaptysbio, Inc | COM | 4,633,602 | $8,614 萬 | 9.8% | +3,764,720+433.3% | 加碼 | 歷史 |
| AXGNAxogen, Inc. | COM | 4,474,215 | $8,277 萬 | 9.5% | −32,580−0.7% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 4,874,124 | $7,009 萬 | 8.0% | −931,060−16.0% | 減碼 | 歷史 |
| NEONeogenomics Inc | COM NEW | 6,042,822 | $5,735 萬 | 6.5% | +2,875,237+90.8% | 加碼 | 歷史 |
| TWSTTwist Bioscience Corp | COM | 1,218,699 | $4,785 萬 | 5.5% | −7,556−0.6% | 減碼 | 歷史 |
| HCATHealth Catalyst, Inc. | COM | 10,436,807 | $4,728 萬 | 5.4% | +5,195,686+99.1% | 加碼 | 歷史 |
| ATRCAtriCure, Inc. | COM | 1,314,718 | $4,241 萬 | 4.8% | −654,503−33.2% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,852,290 | $4,075 萬 | 4.7% | +1,071,651+137.3% | 加碼 | 歷史 |
| PHLTPerformant Healthcare Inc | COM | 11,693,033 | $3,461 萬 | 4.0% | +346,384+3.1% | 加碼 | 歷史 |
| IRTCiRhythm Holdings, Inc. | COM | 325,046 | $3,403 萬 | 3.9% | −105,454−24.5% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 855,419 | $2,869 萬 | 3.3% | −30,034−3.4% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 1,175,879 | $2,824 萬 | 3.2% | −85,367−6.8% | 減碼 | 歷史 |
| MDXGMimedx Group, Inc. | COM | 3,453,074 | $2,624 萬 | 3.0% | +109,213+3.3% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 632,033 | $2,289 萬 | 2.6% | −131,574−17.2% | 減碼 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 1,612,408 | $2,262 萬 | 2.6% | +475,426+41.8% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 627,904 | $2,107 萬 | 2.4% | −532,676−45.9% | 減碼 | 歷史 |
| NPCENeuroPace Inc | COM | 1,584,048 | $1,947 萬 | 2.2% | +1,584,048 | 新進 | 歷史 |
| ALHCAlignment Healthcare, Inc. | COM | 956,441 | $1,781 萬 | 2.0% | +956,441 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 658,824 | $1,779 萬 | 2.0% | +345,042+110.0% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 336,870 | $1,375 萬 | 1.6% | +336,870 | 新進 | 歷史 |
| BFLYButterfly Network, Inc. | COM CL A | 5,505,649 | $1,255 萬 | 1.4% | +1,511,029+37.8% | 加碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 271,115 | $1,155 萬 | 1.3% | −38,274−12.4% | 減碼 | 歷史 |
| KRMDKORU Medical Systems, Inc. | COM | 4,454,926 | $1,132 萬 | 1.3% | −1,460,508−24.7% | 減碼 | 歷史 |
| RGENRepligen Corp | COM | 87,850 | $1,118 萬 | 1.3% | +5,395+6.5% | 加碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,328,768 | $789.5 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| MASS908 Devices Inc. | COM | 1,701,095 | $762.1 萬 | 0.9% | +1,701,095 | 新進 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 107,860 | $725.7 萬 | 0.8% | −31,897−22.8% | 減碼 | 歷史 |
| OSCROscar Health, Inc. | CL A | 522,302 | $684.7 萬 | 0.8% | −24,520−4.5% | 減碼 | 歷史 |
| FNAParagon 28, Inc. | COM | 500,000 | $653.0 萬 | 0.7% | −10,080,467−95.3% | 減碼 | 歷史 |
| EVHEvolent Health, Inc. | CL A | 585,436 | $554.4 萬 | 0.6% | +531,816+991.8% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 68,153 | $519.9 萬 | 0.6% | −402,039−85.5% | 減碼 | 歷史 |
| TNDMTandem Diabetes Care Inc | COM NEW | 245,257 | $469.9 萬 | 0.5% | −46,860−16.0% | 減碼 | 歷史 |
| PODDInsulet Corp | Stock | 17,022 | $447.0 萬 | 0.5% | −16,799−49.7% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 94,420 | $356.5 萬 | 0.4% | +94,420 | 新進 | 歷史 |
| SENSSenseonics Holdings, Inc. | COM | 4,657,505 | $305.6 萬 | 0.3% | −1,774,294−27.6% | 減碼 | 歷史 |
| Direxion Daily S&P Biotech Bear 3X Shares25490K745 | Common Stocks | 140,282 | $230.3 萬 | 0.3% | +140,282 | 新進 | – |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 132,380 | $229.1 萬 | 0.3% | −266,475−66.8% | 減碼 | 歷史 |
2024 年第 4 季之後清倉（5 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| PLRXPliant Therapeutics, Inc. | COM | 1,681,110 | $2,214 萬 | 2.1% | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 383,310 | $1,542 萬 | 1.5% | 歷史 |
| NTRANatera, Inc. | COM | 93,088 | $1,474 萬 | 1.4% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 420,431 | $990.5 萬 | 0.9% | 歷史 |
| iShares Russell 2000 Growth ETF464287648 | ETF | 1,208 | $34.8 萬 | <0.1% | – |